Page 2 - Best Immunotherapy with Keytruda (Pembolizumab) doctors: TOP 61 doctors

Head of Neurooncology Clinic at Sourasky Medical Center (Ichilov) – specializes in advanced cancer treatments.

• Leads a dedicated team for neurooncology cases
• Focuses on innovative therapies like immunotherapy
• Works at one of Israel's top medical centers

Professor Axel Stang leads the oncology department at Asklepios Barmbek Clinic, specializing in advanced antibody and molecular therapies for tumors.

• Head Physician of hematology, oncology, and palliative care since 2010
• Expert in sarcoma treatment and metastatic colon cancer
• Conducts weekly case conferences for personalized treatment plans
• Member of European Society of Medical Oncology (ESMO)
• Researched liver embolization techniques to target cancer cells

Director of children's hematology oncology at Sourasky Medical Center, specializing in bone cancer (sarcoma) and blood disorders.

• Senior pediatrician at Children's Hospital 'Dana'
• Specializes in pediatric hematology and oncology
• Member of the Israeli association ISPHO
• Studied oncology bone and soft tissue in Italy's Rizzoli Orthopaedic Institute

Dr. Fredi Aviv brings 34 years of experience of oncohematology expertise to immunotherapy treatments at Sourasky Medical Center (Ichilov Clinic).

• Specializes in hematologic oncology and immunotherapy
• Practices at a leading medical center in Israel
• Extensive experience with cutting-edge cancer treatments

Director of oncology hospitalization at Tel Aviv Medical Center, Ichilov – Dr. Stepfansky brings extensive clinical and research expertise to immunotherapy cases.

• Over 26 years of experience of experience in oncology and internal medicine
• Actively involved in Phase I-III clinical trials for new cancer treatments
• Specialized training in oncology from Tel Aviv Medical Center, Ichilov
• Holds multiple research roles in cutting-edge immunotherapy studies

Dr. Yair specializes in hematology with a focus on chronic lymphocytic leukemia – recognized with multiple awards for his research and clinical excellence.

• Recipient of the Klitzberg Oncology Award and other prestigious honors
• Member of both Israeli and American Hematology Associations
• Trained at top medical centers in Israel
• Published extensively in hematology research

Dr. Sonnenblick Amir specializes in targeted therapies for breast cancer, including immunotherapy with Keytruda (Pembolizumab). He's recognized with multiple awards for his contributions to oncology research.

• ESMO Breast Cancer Translational and Clinical Research Fellowship at Jules Bordet Institute
• Over 30 presentations at national and international scientific meetings
• Recipient of the ESMO Breast Cancer Translational Research Award
• Member of European Society of Medical Oncology (ESMO)

Specializes in immunotherapy for tumor diseases, with expertise in Keytruda (Pembrolizumab). Recognized for molecular biology research in cancer treatment.

• Chief Physician at certified interdisciplinary cancer center BKZ Solingen
• Active member of American Association for Cancer Research
• Specializes in chemotherapy, immunotherapy, and targeted therapies
• Qualified specialist in genetics
• Works closely with leading haematologists

Dr. Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers, bringing focused expertise to immunotherapy treatments.

• Associate Professor since 2016
• Experienced across multiple oncology departments in Turkey
• Graduated from Selcuk University's Faculty of Medicine

Dr. Ozden brings over 27 years of experience of medical oncology experience to his role at VM Medical Park Pendik Hospital.

• Specialized in Medical Oncology at Kocaeli University
• Graduated from Istanbul University's English Medical Program
• Worked across multiple hospitals specializing in internal medicine

Assoc. Prof. Nail Paksoy specializes in immunotherapy at Medipol Bahçelievler Hospital, with extensive experience in clinical trials involving Keytruda.

• ESMO Board Certified in Medical Oncology
• Subinvestigator in multiple international immunotherapy trials
• Published research on advanced cancer treatments
• Dual fellowship in Medical Oncology and Allergy-Immunology

Dr. Alemdar specializes in immunotherapy with Keytruda at Medical Park Antalya Hospital Complex, bringing extensive experience in medical oncology.

• Board-certified in medical oncology since 2018
• Over 20 years of experience of experience in internal medicine and oncology
• Worked at Akdeniz University Hospital, a leading medical institution

Professor Cicin specializes in immunotherapy at İstinye University Liv Hospital Topkapı, with over 29 years of experience in medical oncology.

• Fellowship-trained in medical oncology at Trakya University
• Professor at Trakya University Faculty of Medicine
• Extensive experience in treating cancer patients with immunotherapy

Dr. Weidmann heads the Hematology sector at Nordwest Clinic with 36 years of experience in blood disorder treatment.

• Specializes in non-Hodgkin lymphoma cases
• Professor with extensive academic credentials
• Works at Nordwest Clinic – a leading hematology center

Dr. Auala Hubert brings 36 years of experience of expertise in oncology and radiotherapy at Hadassah Medical Center, specializing in immunotherapy.

• Heads the Gastrointestinal Cancer Center – deep expertise in complex cases
• Trained at Hadassah University Hospital – one of Israel's leading oncology centers
• Active member of multiple cancer research and treatment committees

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Professor Bosch leads global research in Chronic Lymphocytic Leukemia (CLL) and lymphoma treatments, with over 80 active clinical trials.

• Specializes in lymphomas and CLL at Hospital Quiron Barcelona
• Published 100+ articles in top journals like NEJM and Nature Medicine
• Head of Hematology at Vall d'Hebron University Hospital
• Develops new therapeutic approaches for lymphoproliferative disorders